PODD (STOCKS)
Insulet Corporation
$143.580000
-1.480000 (-1.02%)
Prev close: $145.060000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Ashley A. McEvoy
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $10,149.29M
- Employees
- 3,900
- P/E (TTM)
- 28.76
- P/B (TTM)
- 7.07
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $3.05B |
| Benefits Costs and Expenses | $2.56B |
| Cost Of Revenue | $883.20M |
| Costs And Expenses | $2.56B |
| Gross Profit | $2.17B |
| Operating Expenses | $1.65B |
| Selling, General, and Administrative Expenses | $1.31B |
| Research and Development | $345.90M |
| Operating Income/Loss | $515.80M |
| Income/Loss From Continuing Operations After Tax | $375.40M |
| Income/Loss From Continuing Operations Before Tax | $494.70M |
| Income Tax Expense/Benefit | $119.30M |
| Net Income/Loss | $375.30M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $375.30M |
| Net Income/Loss Available To Common Stockholders, Basic | $375.30M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $5.35 |
| Diluted Earnings Per Share | $5.34 |
| Basic Average Shares | 140,014,000 |
| Diluted Average Shares | 140,058,000 |
| Assets | $3.17B |
| Current Assets | $1.85B |
| Inventory | $484.80M |
| Other Current Assets | $1.36B |
| Noncurrent Assets | $1.32B |
| Liabilities | $1.74B |
| Current Liabilities | $744.20M |
| Accounts Payable | $123.30M |
| Other Current Liabilities | $620.90M |
| Noncurrent Liabilities | $998.70M |
| Equity | $1.42B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.42B |
| Liabilities And Equity | $3.17B |
| Net Cash Flow From Operating Activities | $511.20M |
| Net Cash Flow From Operating Activities, Continuing | $511.20M |
| Net Cash Flow From Investing Activities | -$248.90M |
| Net Cash Flow From Investing Activities, Continuing | -$248.90M |
| Net Cash Flow From Financing Activities | -$845.40M |
| Net Cash Flow From Financing Activities, Continuing | -$845.40M |
| Exchange Gains/Losses | -$3.60M |
| Net Cash Flow | -$586.70M |
| Net Cash Flow, Continuing | -$583.10M |
| Comprehensive Income/Loss | $361.80M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $361.80M |
| Other Comprehensive Income/Loss | $361.80M |
| Other Comprehensive Income/Loss Attributable To Parent | -$13.40M |